From Glioblastoma Treatments
Jump to navigationJump to search
| Display title | Anlotinib |
| Default sort key | Anlotinib |
| Page length (in bytes) | 2,893 |
| Namespace ID | 0 |
| Page ID | 57628 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
View the protection log for this page.
Edit history
| Page creator | Lazy (talk | contribs) |
| Date of page creation | 19:44, 13 June 2024 |
| Latest editor | Lazy (talk | contribs) |
| Date of latest edit | 19:45, 13 June 2024 |
| Total number of edits | 2 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
| Transcluded template (1) | Template used on this page:
|
